| | | Single nucleotide variant (missense variant +1 more) | Developmental and epileptic encephalopathy 96 | |
| | | Single nucleotide variant (missense variant +3 more) | Progressive myoclonic epilepsy +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | not provided | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Progressive myoclonic epilepsy +3 more | GConflicting classifications of pathogenicity |
| | GOSR2, LOC126862578 +1 more (I23V +2 more) | Single nucleotide variant (missense variant +1 more) | Progressive myoclonic epilepsy +1 more | |
| | GOSR2, LOC126862578 +1 more (R69Q +2 more) | Single nucleotide variant (missense variant +1 more) | Progressive myoclonic epilepsy +1 more | |
| | GOSR2, LOC126862578 +1 more (V76I +2 more) | Single nucleotide variant (missense variant +1 more) | Progressive myoclonic epilepsy +1 more | |
| | GOSR2, LRRC37A2 (T108P +2 more) | Single nucleotide variant (missense variant +1 more) | Progressive myoclonic epilepsy +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Progressive myoclonic epilepsy type 6 +3 more | GPathogenic/Likely pathogenic |
| | GOSR2, LRRC37A2 (E122K +2 more) | Single nucleotide variant (missense variant +2 more) | Progressive myoclonic epilepsy +2 more | |
| | GOSR2, LRRC37A2 (G132R +2 more) | Single nucleotide variant (missense variant +2 more) | not provided | |
| | GOSR2, LRRC37A2 (N170S +5 more) | Single nucleotide variant (missense variant +1 more) | Progressive myoclonic epilepsy type 6 +3 more | |